Cann Group Annual Report 2022-23

Australia's first licensed medicinal cannabis company. An industry still finding its feet, so the report had to feel credible, clinical and forward-looking — all while navigating the regulatory and investor scrutiny that comes with the territory. A refined, minimal aesthetic with botanical touches that nod to the product without leaning into cliché.